UNSPSC 51373317: Aluminum hydroxide/aspirin/codeine/magnesium hydroxide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373317 Aluminum hydroxide/aspirin/codeine/magnesium hydroxide is a Commodity code that in practice captures state and local procurement of pharmaceuticals and over-the-counter (OTC) products, including naloxone, generic multi-source drugs, and specialized pharmaceutical systems. State and local health departments, cooperative purchasing alliances, and county health agencies solicit under this code to supply medications and medical products to community health facilities, employee health plans, and public health initiatives. The scope of work ranges from emergency-response pharmaceuticals like naloxone for community health programs to broad-based generic drug procurement for multi-jurisdictional distribution through authorized wholesalers. Issuers include state health and human services commissions, county health departments, and multi-state cooperative purchasing organizations that aggregate demand across member jurisdictions.

Recent activity centers in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, requiring unit pricing and E-Verify compliance on a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on vendors' experience with direct contracting, negotiated net pricing models, and value-based agreements outside traditional pharmacy benefit manager and wholesaler arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for multiple contracts covering generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), with award effective July 1, 2026, requiring vendors to certify cGMP and Drug Supply Chain Security Act compliance and maintain $5,000,000 commercial general liability coverage.